02.03.2014 Views

National Survey of Research Commercialisation - Australian ...

National Survey of Research Commercialisation - Australian ...

National Survey of Research Commercialisation - Australian ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Table 11: Licences executed — to start-up, small, medium or large companies, Year 2000<br />

(for respondents that provided data)<br />

COMMERCIAL ACTIVIT Y<br />

Total Licences<br />

Executed<br />

Start-up<br />

Companies<br />

Percent <strong>of</strong><br />

Total<br />

Small<br />

Companies<br />

Percent <strong>of</strong><br />

Total<br />

Medium<br />

Companies<br />

Percent <strong>of</strong><br />

Total<br />

Large<br />

Companies<br />

Percent <strong>of</strong><br />

Total<br />

Universities 204 35 17 48 24 22 11 99 49<br />

Medical <strong>Research</strong> Institutes 15 6 40 1 7 5 33 3 20<br />

CSIRO 117 18 15 14 12 14 12 71 61<br />

Total 336 59 18 63 19 41 12 173 51<br />

A significant proportion <strong>of</strong> licensing activity is focused on small companies, with 47% <strong>of</strong> medical<br />

research institute licences, 41% <strong>of</strong> university licences and 27% <strong>of</strong> CSIRO licences executed to start-up or<br />

small companies.<br />

Of the 417 licences executed by universities, medical research institutes and CSIRO in<br />

Year 2000, 335 (80%) were reported as either exclusive or non-exclusive and as being<br />

executed to start-up, small, medium or large companies:<br />

<strong>of</strong> the licences executed to start-up companies, 86% were exclusive and 14% were<br />

non-exclusive.<br />

<strong>of</strong> the licences executed to small companies, 48% were exclusive and 52% were<br />

non-exclusive.<br />

<strong>of</strong> the licences executed to medium companies, 54% were exclusive and 46% were<br />

non-exclusive.<br />

<strong>of</strong> the licences executed to large companies, 29% were exclusive and 71% were<br />

non-exclusive.<br />

The very high proportion <strong>of</strong> exclusive licences executed to start-up companies suggests that the ability<br />

to grant exclusive licences is important to company start-up activity, an important contribution to the<br />

overall economic impact <strong>of</strong> licensing by universities, medical research institutes and CSIRO.<br />

B) INCOME PATTERNS<br />

The survey sought information from institutions about the number <strong>of</strong> licences that yielded<br />

income in Year 2000 and the amount <strong>of</strong> income they received from these licences in that<br />

year, in the form <strong>of</strong> running royalties, cashed-in equity and all other types <strong>of</strong> income.<br />

Income from licences<br />

The 491 licences that were executed by universities, medical research institutes and CSIRO and which<br />

yielded income in Year 2000, yielded gross income amounting to $103.6 million and adjusted gross<br />

income 7 amounting to $99.4 million in Year 2000.<br />

7<br />

Adjusted gross income from licences is gross income from licences minus licence income paid to other<br />

institutions. The subtraction <strong>of</strong> licence income paid to other institutions from gross income from licences<br />

removes a possible double count in the licence income data that may occur from the reporting <strong>of</strong> the same<br />

income by more than one institution.<br />

31

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!